動物用治療薬市場：製品、動物、投与経路、エンドユーザー別-2025-2030年の世界予測

動物用治療薬市場は、2023年に380億5,000万米ドルと評価され、2024年には407億7,000万米ドルに達すると予測され、CAGR 7.23%で成長し、2030年には620億4,000万米ドルに達すると予測されています。

動物用治療薬市場には、動物医療用に設計された医薬品、ワクチン、診断ツールなど幅広い製品が含まれます。世界のペット飼育の増加と畜産物に対する需要の高まりにより、この市場は人獣共通感染症の蔓延の増加と高度な動物ヘルスケアソリューションの必要性に対応しています。動物用治療薬は、ペットの飼い主、動物病院、畜産農家など幅広いエンドユーザーにおいて、疾病の予防、制御、治療に応用されています。市場に影響を与える主な成長要因としては、医薬品開発における技術的発展、動物ヘルスケアに対する意識の高まり、政府の取り組みの強化などが挙げられます。最近の潜在的なビジネスチャンスは、ペットの人間化傾向の高まり、バイオ医薬品の進歩、獣医学的ニーズが十分に満たされていない新興市場への進出にあります。さらに、デジタル・ソリューションと遠隔医療は、獣医療を合理化する大きな可能性を秘めています。しかし、市場は厳しい規制政策、高い開発コスト、偽造品の出現といった課題に直面しており、これが成長を阻害する可能性があります。さらに、新興国市場には十分な獣医学的インフラが整っていないため、市場の拡大には限界があります。技術革新の機が熟している分野には、精密医療、ゲノミクス、診断におけるAIの利用などがあり、これらは治療プロトコルの精度と有効性を高めることができます。もう一つの有望な分野は、持続可能で環境に優しい治療製品の開発であり、環境に配慮したソリューションに対する需要の高まりに応えるものです。市場は競合情勢が特徴で、大手製薬会社は製品ラインナップを拡大するために研究や提携に投資しています。新たなビジネスチャンスを活かすため、利害関係者は製品ポートフォリオの多様化、最先端研究への投資、進化する消費者の期待や規制状況との戦略調整に注力すべきです。全体として、動物用治療薬市場は、絶え間ない技術革新と、世界の健康動態における動物用医薬品の重要性の認識の拡大により、大きく成長する態勢が整っています。

市場力学：急速に進化する動物用治療薬市場の主要市場インサイトを公開

動物用治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • コンパニオンアニマルおよび家畜の飼育数の増加
  • 経済国における動物医療施設の改善
  • 動物の慢性疾患や事故による怪我の発生率の増加
• 市場抑制要因
  • 動物用治療薬の高コスト
• 市場機会
  • 各国における新製品承認の増加
  • 新規治療薬開発のための研究開発活動の活発化
• 市場の課題
  • 品質管理の問題

ポーターの5つの力動物用治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用治療薬市場における外部からの影響の把握

外部マクロ環境要因は、動物用治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用治療薬市場における競合情勢の把握

動物用治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用治療薬市場における成功への道筋を描く

動物用治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットや家畜の飼育数の増加
    • 経済における獣医ケア施設の改善
    • 動物の慢性疾患や事故による傷害の発生率の上昇
  • 抑制要因
    • 動物用治療薬のコストが高い
  • 機会
    • 経済における新製品承認の増加
    • 新しい治療法の開発に向けた研究開発活動の強化
  • 課題
    • 品質管理の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用治療薬市場：製品別

• 薬剤の種類
  • 抗炎症
  • 反罵倒
  • 寄生虫駆除剤
• 医薬品添加飼料添加物
  • アミノ酸
  • 抗生物質
  • オンライン薬局
  • 小売薬局
• ワクチンの種類
  • 弱毒化ワクチン
  • 不活化ワクチン
  • 組み換えワクチン

第7章 動物用治療薬市場：動物別

• ペット
• 家畜

第8章 動物用治療薬市場：投与経路別

• オーラル
• 非経口
• 話題

第9章 動物用治療薬市場：エンドユーザー別

• 薬局・ドラッグストア
• 獣医クリニック
• 動物病院

第10章 南北アメリカの動物用治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の動物用治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Biogenesis Bago SA
• Biovac Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Chanelle Pharma Unlimited
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Eli Lilly and Company
• Heska Corporation
• Hester Biosciences Limited
• IDEXX Laboratories Inc.
• ImmuCell Corporation
• Indian Immunologicals Ltd.
• Merck & Co. Inc.
• Neogen Corporation
• Novartis International AG
• Nutreco N.V.
• Phibro Animal Health Corporation
• Vetoquinol Group
• Zoetis, Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INVECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACIES & DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 60. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 62. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 96. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 97. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 98. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 99. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 103. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 104. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 105. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 106. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 223. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 224. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 225. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 226. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 227. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 249. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 251. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 252. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 253. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 254. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 255. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 256. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 257. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 258. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 259. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 260. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 261. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 262. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 326. VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 327. VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Veterinary Therapeutics Market was valued at USD 38.05 billion in 2023, expected to reach USD 40.77 billion in 2024, and is projected to grow at a CAGR of 7.23%, to USD 62.04 billion by 2030.

The scope of the veterinary therapeutics market encompasses a wide range of products including pharmaceuticals, vaccines, and diagnostic tools designed for animal health care. Necessitated by the rising global pet ownership and the growing demand for livestock products, this market responds to the increasing prevalence of zoonotic diseases and the need for advanced animal healthcare solutions. Veterinary therapeutics are applied in the prevention, control, and treatment of diseases across a broad spectrum of end-users such as pet owners, veterinary hospitals, and livestock farmers. Key growth factors influencing the market include technological advances in drug development, rising animal healthcare awareness, and increased government initiatives. Recent potential opportunities lie in the growing trend of humanization of pets, the advancement of biopharmaceuticals, and the expansion into emerging markets with underserved veterinary needs. Moreover, digital solutions and telemedicine offer significant potential to streamline veterinary care. However, the market faces challenges such as stringent regulatory policies, high development costs, and the emergence of counterfeit products, which can stifle growth. Additionally, the lack of adequate veterinary infrastructure in developing regions limits market proliferation. Areas ripe for innovation include precision medicine, genomics, and the use of AI in diagnostics, which can enhance the accuracy and efficacy of treatment protocols. Another promising area is the development of sustainable and environmentally friendly therapeutic products, catering to the increasing demand for eco-conscious solutions. The market is characterized by a competitive landscape with major pharmaceutical companies investing in research and partnerships to expand their product offerings. To capitalize on emerging opportunities, stakeholders should focus on diversifying product portfolios, investing in cutting-edge research, and aligning strategies with evolving consumer expectations and regulatory landscapes. Overall, the veterinary therapeutics market is poised for substantial growth driven by continuous innovation and the expanding recognition of the importance of animal health in global health dynamics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Therapeutics Market

The Veterinary Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Improving veterinary care facilities in economies
  • Rising incidence of chronic diseases and accidental injuries in animals
• Market Restraints
  • High cost of veterinary therapeutics
• Market Opportunities
  • Growing new product approvals in economies
  • Increasing R&D activities to develop new therapeutics
• Market Challenges
  • Issues with quality management

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Therapeutics Market

A detailed market share analysis in the Veterinary Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Therapeutics Market

A strategic analysis of the Veterinary Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Unlimited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories Inc., ImmuCell Corporation, Indian Immunologicals Ltd., Merck & Co. Inc., Neogen Corporation, Novartis International AG, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol Group, and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Drug Type, Medicated Feed Additive, and Vaccines Type. The Drug Type is further studied across Anti-Inflammatory, Anti-Invectives, and Parasiticides. The Medicated Feed Additive is further studied across Amino Acids, Antibiotics, Online Pharmacy, and Retail Pharmacy. The Vaccines Type is further studied across Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines.
• Based on Animal, market is studied across Companion Animal and Livestock Animal.
• Based on Route of Administration, market is studied across Oral, Parenteral, and Topical.
• Based on End User, market is studied across Pharmacies & Drug Store, Veterinary Clinic, and Veterinary Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Improving veterinary care facilities in economies
    • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary therapeutics
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing new product approvals in economies
    • 5.1.3.2. Increasing R&D activities to develop new therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Issues with quality management
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Therapeutics Market, by Product

• 6.1. Introduction
• 6.2. Drug Type
  • 6.2.1. Anti-Inflammatory
  • 6.2.2. Anti-Invectives
  • 6.2.3. Parasiticides
• 6.3. Medicated Feed Additive
  • 6.3.1. Amino Acids
  • 6.3.2. Antibiotics
  • 6.3.3. Online Pharmacy
  • 6.3.4. Retail Pharmacy
• 6.4. Vaccines Type
  • 6.4.1. Attenuated Vaccines
  • 6.4.2. Inactivated Vaccines
  • 6.4.3. Recombinant Vaccines

7. Veterinary Therapeutics Market, by Animal

• 7.1. Introduction
• 7.2. Companion Animal
• 7.3. Livestock Animal

8. Veterinary Therapeutics Market, by Route of Administration

• 8.1. Introduction
• 8.2. Oral
• 8.3. Parenteral
• 8.4. Topical

9. Veterinary Therapeutics Market, by End User

• 9.1. Introduction
• 9.2. Pharmacies & Drug Store
• 9.3. Veterinary Clinic
• 9.4. Veterinary Hospital

10. Americas Veterinary Therapeutics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Therapeutics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Therapeutics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biogenesis Bago SA
• 2. Biovac Ltd.
• 3. Boehringer Ingelheim International GmbH
• 4. Ceva Sante Animale
• 5. Chanelle Pharma Unlimited
• 6. Dechra Pharmaceuticals PLC
• 7. Elanco Animal Health Incorporated
• 8. Eli Lilly and Company
• 9. Heska Corporation
• 10. Hester Biosciences Limited
• 11. IDEXX Laboratories Inc.
• 12. ImmuCell Corporation
• 13. Indian Immunologicals Ltd.
• 14. Merck & Co. Inc.
• 15. Neogen Corporation
• 16. Novartis International AG
• 17. Nutreco N.V.
• 18. Phibro Animal Health Corporation
• 19. Vetoquinol Group
• 20. Zoetis, Inc.